Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Calypte opens new office in Geneva
The company named experienced executives Khatuna Janjalia, president and Kartlos Edilashvili, vice president of the Geneva branch office. Ms Janjalia joins Calypte from the Audit Control and Expertise
The company named experienced executives Khatuna Janjalia, president and Kartlos Edilashvili, vice president of the Geneva branch office. Ms Janjalia joins Calypte from the Audit Control and Expertise
With offices in Tokyo, Osaka, Fukuoka and Sapporo, Central Scientific Commerce (CSC) is a subsidiary of GSI Creos Corporation. Mr Clint Severson, chairman and CEO of Abaxis, said:
New data also demonstrated excellent in vitro activity of Enzon’s customized linker technology when applied to the locked nucleic acid (LNA) antagonists, the company said. The study showed
Dr Intae Lee with the University of Pennsylvania presented the pre-clinical in vivo data at the American Society for Therapeutic Radiology and Oncology (ASTRO) 49th Annual Meeting in
The European Commission’s decision to approve Nexavar is based on positive data from the international Phase III placebo-controlled sorafenib hepatocellular carcinoma (HCC) assessment randomized protocol (SHARP) trial, which
The treatment will commence after completion of the initial screening. The study encompasses a total of 12 treatment naive patients with chronic hepatitis C virus genotype 1 infections
The TEG product line, which includes equipment, software and consumables, has been marketed successfully for over seven years. The TEG system is a proven technology backed by scores
With almost 25,000 square feet, the new facility offers a five-times increase in testing capacity, four times the space to produce clinical trial kits, and a wider range
Accuray will supply a version of its RoboCouch robotic patient positioning system, which intelligently positions patients with six degrees of freedom for treatment, enabling clinicians to automatically re-position
As part of a GBP70 million investment to mark its 75th anniversary, The London Clinic will introduce the radiotherapy services to its patients for the first time when